Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience

Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience

Background: Cardiac amyloidosis is a less common indication for orthotopic heart transplantation (OHT). Light chain (AL) amyloidosis specifically poses challenges. While previous small studies have established the validity of OHT for AL amyloidosis, we present experience from a large contemporary se...

Full description

Saved in:
Bibliographic Details
Main Authors: Khush Patel, MD, Zoe H. Tu, PharmD, Carrie Yuen, MD, Siddhartha Ganguly, MD, Allison N. Yun, PharmD, BCTXP, Janardhana R. Gorthi, MD, MBBS, Barry H. Trachtenberg, MD, Ashrith Guha, MD, MPH, Mahwash Kassi, MD, Ju Kim, MD, Rayan Yousefzai, MD, Kelty Baker, MD, Lawrence Rice, MD, Rammurti T. Kamble, MD, Horacio E. Adrogue, MD, Erik E. Suarez, MD, Mark Ghobrial, MD PhD, Ashish Saharia, MD, Constance M. Mobley, MD PhD, David W. Victor, MD, Jill C. Krisl, PharmD, BCPS, BCTXP, Richard Knight, MD, A. Osama Gaber, MD, Arvind Bhimaraj, MD, MPH, FACC, FHFSA
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:JHLT Open
Subjects:
AL amyloidosis
heart transplant
light-chain
cardiac amyloidosis
long term outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133425001235
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items